Volume. 1, July - September, 2012 - amam-ayurveda.org

From the Editor’s desk
Dear Members,
We wish to draw the attention of our readers to two recent developments.
One is regarding the new labeling requirements sought by the Department
of Ayush on ASU drugs and another is related to a news item regarding raids
on three Ayurvedic companies in Kerala for violating Drugs and Magic
Remedies Act.
Recently, department of Ayush issued draft of gazette notification on
revising labelling guidelines as per Rule 161 of D&C Act and Rules.The
department has sought to provide the additional details to be mentioned
on the labels of ISM medicines covering Patent or Proprietary Ayurveda,
Siddha and Unani (ASU) medicines.
As per the draft notification, the label would need to list all the ingredients
with it’s official and botanical names of herbal ingredients along with parts
used and the form of ingredient, in which, it is used in the formulation along
with its quantity.
We at AMAM have taken a serious objection to this move and made a
representation on behalf of our association.
Even if the manufacturers implement the same it may become impractical
since the space on the label is just sufficient to comply with the current
requirement of Rule 161 of the Drugs & Cosmetics Rules.
While we appreciate the intent of the government to make the consumers
more informed, there is a serious practical issue to include these details
which the Department of Ayush needs to consider.
As we all know, that most of the formulations in the Ayurveda texts are
multi-ingredient. Even the Ayurvedic Formulary of India has provided that
Analysis of Ayurvedic Formulations covered in Active Pharmaceutical
Ingredient (API) Vol. I & II covering solids, semi solids and liquids has
detailed the percentage of product containing up to 10 and above 20
ingredients.
Classical ayurvedic formulations have limited no. of manufacturers. The
Ayurvedic industry is apprehensive on the amendment which is currently
circulated as draft notification to seek comments.
We are of the opinion that the move to add extra information on the label
would become counterproductive and may not serve the purpose.
It is possible that this move is aimed to satisfy consumers’ needs and right
to information. Providing additional information on the label may cause
logistical problems. Creative solutions are needed to handle this issue. A
viable move would be to make it mandatory for manufacturers to provide all
details on their websites and mention name of their website on the label.
We are reproducing our letter of representation and a copy of label as an
example else where in this news letter for your perusal and comments.
Our second concern is about the violation of the Drugs and Magic Remedies
Act by manufacturers of ASU drugs.
We appeal to all our fellow members to desist from violating the DMR act
at all costs.
We understand making tall claims may generate some revenue but at the
same time we do not appreciate violation of any law of the land for doing
product promotions or giving misleading advertisements.
Though these raids have happened in Kerala, we urge our members to look
for local regional newspapers, especially on weekends which are flooded
with similar tall claims made by various manufacturers. These types of tall
claims not only violate DMR act but also bring bad name to entire ancient
system of medicine.
Since our sector is very small, we should not do anything which may lead
to questions on authenticity of this age old science. Let us all work together
for the promotion of Ayurved, Sidha and Unani system of medicines in an
ethical way.
Dr. Manju Rakesh
On behalf of full editorial board
Info Ayurveda, Volume 2, No.1, July to September’ 2012
Members of AMAM’S
Management Committee
Patron
Vaidya Brahaspati Dev Triguna
Suresh Sharma
Pradip Burman
Jt. Secretary
Ajay Sharma
Shri Baidyanath Ayurved Bhawan,
New Delhi
E-mail: ajdelhi@msn.com
President
Arun Chauhan
Vaidya Devender Triguna
Tel: 011-24354141
BACFO Pharmaceuticals (India) Ltd.
E-mail: chauhanarun@akcgroup.com
Dr. N.B. Brindavanam
Vice President
Anurag Sharma
Shri Baidyanath Ayurved Bhawan
Ltd., (Jhansi)
E-mail: anurag@baidyanathayurved.com
Dabur India Limited
E-mail: baba@dabur.com
M. J. Saxena
Sanat Laboratories Ltd.
E-mail: mjsaxena@sanatproducts.co.in
Asad Mueed
Hamdard (WAKF) Laboratories Members
E-mail: amueed@hamdardindia.com Vijay Grover
Devendra Garg
Dabur India Limited
Kamal Pharmacy, New Delhi
E-mail: vijay@kamalpharmacy.com
E-mail: gargd@dabur.com
Pramod Sharma
Ravi Prasad
Shri Baidyanath Ayurved Bhawan
The Himalaya Drug Co.
Ltd. Patna
E-mail: ravi.prasad@himalayahealthcare.com E-mail: pramodsharma54@yahoo.com
Dr. Manju Rakesh
Hon. Gen. Secretary
Dabur India Limited
Pradeep Multani
E-mail: rakeshm@dabur.com
Multani Pharmaceuticals Ltd.
e-mail: chairman@multaniayurved.org
Amit Agarwal
Natural Remedies
E-mail: amit@naturalremedies.com
Treasurer
Dr. Anantha Narayana D B,
Tejinder Singh
Dabur India Limited
e-mail: singht@dabur.com
Ph.D., Consultant
Email: dba.narayana@gmail.com
Editorial Board
Chief Editor:
Mr. Pradeep Multani
Honorary General Secretary AMAM
Chairman Multani Pharmaceutical Limited
36-H Connaught place, New Delhi- 1
Editor:
Dr. Manju Rakesh
Dabur India Limited, Plot No. 22, Site IV,
Sahibabad - 201010, Ghaziabad (U.P.)
Mr. Anurag Sharma, Executive Director
Shri Baidyanath Ayurved Bhawan Pvt. Ltd. (Jhansi)
B- 6/5, Safdarjung Enclave, New Delhi
Mr. Asad Mueed, Director
Hamdard (WAKF) Laboratories, Asaf Ali Road, New Delhi – 2
Mr. Ajay Sharma, President
Shri Baidyanath Ayurved Bhawan, Naini,
28, Ishwar Nagar East, New Delhi – 65
Disclaimer: Articles in the newsletter are written by independent individuals. News Clips of
Upcoming Events, Govt. Notifications, Schemes have been taken from different sources. Their
opinions do not necessarily reflect those of Info Ayurveda. They are put here for interest and
reference only. None of the contributors, sponsors, administrators, or anyone else connected with
Info Ayurveda in any way whatsoever shall be responsible for the appearance of any inaccurate
information or for your use of the information contained in the newsletter.
2